SABINA SAMPATH: Open Payments
NPI 1568808475 · FAIR OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 19 payments from 12 companies in 2025. Trend: 2023 $570 · 2024 $487 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 2 | $50 |
| Electromed, Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| QIAGEN, LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
Products named: MOUNJARO, Ozempic, Rybelsus, SMARTVEST, General - Pain Management, JARDIANCE, JOURNAVX, PAXLOVID.
Industry payments across CA — which companies pay providers there.
